These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 30637550)

  • 21. Histopathological Growth Patterns and Survival After Resection of Colorectal Liver Metastasis: An External Validation Study.
    Höppener DJ; Galjart B; Nierop PMH; Buisman FE; van der Stok EP; Coebergh van den Braak RRJ; van Amerongen MJ; Balachandran VP; Jarnagin WR; Kingham TP; Doukas M; Shia J; Nagtegaal ID; Vermeulen PB; Koerkamp BG; Grünhagen DJ; de Wilt JHW; D'Angelica MI; Verhoef C
    JNCI Cancer Spectr; 2021 Jun; 5(3):. PubMed ID: 34056541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biological and Prognostic Significance of the Morphological Types and Vascular Patterns in Colorectal Liver Metastases (CRLM): Looking Beyond the Tumor Margin.
    Siriwardana PN; Luong TV; Watkins J; Turley H; Ghazaley M; Gatter K; Harris AL; Hochhauser D; Davidson BR
    Medicine (Baltimore); 2016 Feb; 95(8):e2924. PubMed ID: 26937938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prognosis of liver resection for patients with four or more colorectal liver metastases has not improved in the era of modern chemotherapy.
    Hokuto D; Nomi T; Yamato I; Yasuda S; Obara S; Yoshikawa T; Kawaguchi C; Yamada T; Kanehiro H; Nakajima Y
    J Surg Oncol; 2016 Dec; 114(8):959-965. PubMed ID: 27683191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The relationship between primary colorectal cancer histology and the histopathological growth patterns of corresponding liver metastases.
    Höppener DJ; Stook JPL; Galjart B; Nierop PMH; Nagtegaal ID; Vermeulen PB; Grünhagen DJ; Verhoef C; Doukas M;
    BMC Cancer; 2022 Aug; 22(1):911. PubMed ID: 35996090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Local tumour control after radiofrequency or microwave ablation for colorectal liver metastases in relation to histopathological growth patterns.
    Vles MD; Höppener DJ; Galjart B; Moelker A; Vermeulen PB; Grünhagen DJ; Verhoef C
    HPB (Oxford); 2022 Sep; 24(9):1443-1452. PubMed ID: 35144863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical implications and mechanism of histopathological growth pattern in colorectal cancer liver metastases.
    Kong BT; Fan QS; Wang XM; Zhang Q; Zhang GL
    World J Gastroenterol; 2022 Jul; 28(26):3101-3115. PubMed ID: 36051338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The clinical relevance of the Fong and the Nordlinger scores in the era of effective neoadjuvant chemotherapy for colorectal liver metastasis.
    Schreckenbach T; Malkomes P; Bechstein WO; Woeste G; Schnitzbauer AA; Ulrich F
    Surg Today; 2015 Dec; 45(12):1527-34. PubMed ID: 25563588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between imaging response and survival following neoadjuvant chemotherapy in patients with resectable colorectal liver metastases: A cohort study.
    Behrenbruch C; Prabhakaran S; Udayasiri D D; Michael M; Hollande F; Hayes I; Heriot AG; Knowles B; Thomson BN
    J Surg Oncol; 2021 Apr; 123(5):1263-1273. PubMed ID: 33524184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of Histopathologic Growth Patterns of Colorectal Liver Metastases with a Noninvasive Imaging Method.
    Cheng J; Wei J; Tong T; Sheng W; Zhang Y; Han Y; Gu D; Hong N; Ye Y; Tian J; Wang Y
    Ann Surg Oncol; 2019 Dec; 26(13):4587-4598. PubMed ID: 31605342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased carcinoembryonic antigen (CEA) following neoadjuvant chemotherapy predicts poor prognosis in patients that undergo hepatectomy for liver-only colorectal metastases.
    Neofytou K; Giakoustidis A; Neves MC; Morrison D; Giakoustidis D; Khan AZ; Stebbing J; Mudan S
    Langenbecks Arch Surg; 2017 Jun; 402(4):599-605. PubMed ID: 27043945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic implications of adaptive immune features in MMR-proficient colorectal liver metastases classified by histopathological growth patterns.
    Messaoudi N; Henault D; Stephen D; Cousineau I; Simoneau E; Rong Z; Létourneau R; Plasse M; Dagenais M; Roy A; Lapointe R; Vandenbroucke-Menu F; Kunda R; Ysebaert D; Soucy G; Stagg J; Vermeulen P; Turcotte S
    Br J Cancer; 2022 May; 126(9):1329-1338. PubMed ID: 34980880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic review of systemic adjuvant, neoadjuvant and perioperative chemotherapy for resectable colorectal-liver metastases.
    Khoo E; O'Neill S; Brown E; Wigmore SJ; Harrison EM
    HPB (Oxford); 2016 Jun; 18(6):485-93. PubMed ID: 27317952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Validated Prognostic Multigene Expression Assay for Overall Survival in Resected Colorectal Cancer Liver Metastases.
    Balachandran VP; Arora A; Gönen M; Ito H; Turcotte S; Shia J; Viale A; Snoeren N; van Hooff SR; Rinkes IH; Adam R; Kingham TP; Allen PJ; DeMatteo RP; Jarnagin WR; D'Angelica MI
    Clin Cancer Res; 2016 May; 22(10):2575-82. PubMed ID: 26733613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prognostic value of preoperative serum lactate dehydrogenase levels in patients underwent curative-intent hepatectomy for colorectal liver metastases: A two-center cohort study.
    Bai L; Lin ZY; Lu YX; Chen Q; Zhou H; Meng Q; Lin CP; Huang WL; Wan YL; Pan ZZ; Wang DS
    Cancer Med; 2021 Nov; 10(22):8005-8019. PubMed ID: 34636145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical risk scores in the current era of neoadjuvant chemotherapy for colorectal liver metastases.
    Kumar R; Dennison AR; Robertson V; Jones MJ; Neal CP; Garcea G
    ANZ J Surg; 2018 Jan; 88(1-2):E16-E20. PubMed ID: 27621179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histopathological growth patterns modify the prognostic impact of microvascular invasion in non-cirrhotic hepatocellular carcinoma.
    Meyer YM; Beumer BR; Höppener DJ; Nierop PMH; Doukas M; de Wilde RF; Sprengers D; Vermeulen PB; Verhoef C; IJzermans JNM
    HPB (Oxford); 2022 Apr; 24(4):507-515. PubMed ID: 34393042
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reconsideration of the indications for adjuvant chemotherapy for liver metastases from colorectal cancer after initial hepatectomy.
    Hirokawa F; Hayashi M; Miyamoto Y; Asakuma M; Shimizu T; Komeda K; Inoue Y; Uchiyama K
    Ann Surg Oncol; 2014 Jan; 21(1):139-46. PubMed ID: 24121880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Comprehensive Prognostic Model for Colorectal Cancer Liver Metastasis Recurrence After Neoadjuvant Chemotherapy.
    Zhou Z; Han X; Sun D; Liang Z; Wu W; Ju H
    Front Oncol; 2022; 12():855915. PubMed ID: 35785215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival and Prognostic Factors of Colorectal Liver Metastases After Surgical and Nonsurgical Treatment.
    Lemke J; Cammerer G; Ganser J; Scheele J; Xu P; Sander S; Henne-Bruns D; Kornmann M
    Clin Colorectal Cancer; 2016 Dec; 15(4):e183-e192. PubMed ID: 27269232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is neoadjuvant chemotherapy appropriate for patients with resectable liver metastases from colorectal cancer?
    Hirokawa F; Asakuma M; Komeda K; Shimizu T; Inoue Y; Kagota S; Tomioka A; Uchiyama K
    Surg Today; 2019 Jan; 49(1):82-89. PubMed ID: 30255329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.